Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,157
NCT01661634
Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure
Phase: Phase 3
Role: Lead Sponsor
Start: Jul 31, 2012
Completion: Mar 31, 2016